Vizora日本語

ReproCELLReproCELL Incorporated4978東証グロース化学FY ending Mar 2026, consolidated, J-GAAP

ReproCELL FY ending Mar 2024 results

About 86% of ReproCELL's sales come from Research Support Business, with Medical Business making up much of the rest.

It lost about ¥17 for every ¥100 of sales at the operating level.

Revenue changed -17.8% from the prior year.

What changed from last year

FY ending Mar 2023 → FY ending Mar 2024

Revenue
-17.8%¥2.95B → ¥2.43B
Gross profit
-1.8%¥1.14B → ¥1.12B
Operating income
Loss-¥356.2M → -¥409.3M
Net income attributable to owners
Loss-¥305.3M → -¥31.4M
Operating cash flow
Loss-¥140.5M → -¥11.5M
Free cash flow
Loss-¥301.6M → -¥203.9M

Where the money goes

FY ending Mar 2023 → FY ending Mar 2024

Where ¥100 of sales goes

For every ¥100 ReproCELL sells, how much goes where, and how much is kept.

FY ending Mar 2024
Cost of sales
¥54
SG&A
¥63
Operating loss
¥17
Net loss
¥1

Annual margin trends

Gross margin46.2%
FY ending Mar 2020: 39.6%39.6%FY ending Mar 2021: 37.5%37.5%FY ending Mar 2022: 36.0%36.0%FY ending Mar 2023: 38.6%38.6%FY ending Mar 2024: 46.2%46.2%FY20FY21FY22FY23FY24
Operating margin-16.9%
FY ending Mar 2020: -75.8%-75.8%FY ending Mar 2021: -81.5%-81.5%FY ending Mar 2022: -29.0%-29.0%FY ending Mar 2023: -12.1%-12.1%FY ending Mar 2024: -16.9%-16.9%FY20FY21FY22FY23FY24
Net margin-1.3%
FY ending Mar 2020: -84.7%-84.7%FY ending Mar 2021: -63.2%-63.2%FY ending Mar 2022: -25.7%-25.7%FY ending Mar 2023: -10.3%-10.3%FY ending Mar 2024: -1.3%-1.3%FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2024

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第24期(2025/04/01－2026/03/31)

    ID S100YLVF2026-06-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第23期(2024/04/01－2025/03/31)

    ID S100W6LK2025-06-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第22期(2023/04/01－2024/03/31)

    ID S100TRSE2024-06-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第21期(2022/04/01－2023/03/31)

    ID S100R5G82023-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(令和3年4月1日－令和4年3月31日)

    ID S100OJYY2022-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(令和2年4月1日－令和3年3月31日)

    ID S100LSLF2021-06-28Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image